Data updated: Mar 29, 2026

MEDEXUS

Oncology

Pharma

MEDEXUS is a pharmaceutical company focused on Oncology. Key products include GRAFAPEX.

2014

Since

2

Drugs

-

Trials

2

Approved (2yr)

Key Drugs

2 indications · 2025

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

GRAFAPEX 2025-02-05

GRAFAPEX 2025-01-21

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma